Trial of an Ayurvedic drug in Hepatitis B cases
Phase 2
- Conditions
- Health Condition 1: K70-K77- Diseases of liver
- Registration Number
- CTRI/2021/07/034576
- Lead Sponsor
- Department of Kayachikitsa
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
HBV DNA >2000IU/ml
Prothrombin time upto 18 seconds and INR upto 2
Patients diagnosed with classical features of Hepatitis B.
Exclusion Criteria
Prothrombin time >18 seconds and INR >2.
Hepatitis B patients with complications like ascites,TB,portal hypertension, asthma, hepatocellular carcinoma and AIDS.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assesment will be done on the basis of prepared proforma for assesment of subjective parameter and serological markers like HBV DNA.Timepoint: The follow up interval will be 1 month for 3 consecutive months.
- Secondary Outcome Measures
Name Time Method Assesment of improvement in symptoms of Hepatitis B.Timepoint: The follow up interval will be 1 month for 3 consecutive months.